CONDUIT PHARMACEUTICALS INC. Quarterly Share-based Payment Arrangement, Expense in USD for Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Conduit Pharmaceuticals Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate for Q3 2023.
Conduit Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $10K.

Share-based Payment Arrangement, Expense, Quarterly (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023		$10K			Jul 1, 2023	Sep 30, 2023	10-Q/A	2023-11-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.